The latest research has disclosed that nicotinamide riboside ameliorate high-fructose-induced lipid metabolism disorder may be related to the regulation of inflammation mediated by the SIRT1/NF-κB signaling pathway [37]. The gene discussed is NFKB1; the disease is Disorder of lipid metabolism.